These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11796256)

  • 1. Three steps to targeting anthrax toxin.
    Lindsay J
    Trends Mol Med; 2002 Jan; 8(1):6. PubMed ID: 11796256
    [No Abstract]   [Full Text] [Related]  

  • 2. War against anthrax.
    Khanna H; Singh Y
    Mol Med; 2001 Dec; 7(12):795-6. PubMed ID: 11844866
    [No Abstract]   [Full Text] [Related]  

  • 3. Tackling anthrax.
    Friedlander AM
    Nature; 2001 Nov; 414(6860):160-1. PubMed ID: 11700539
    [No Abstract]   [Full Text] [Related]  

  • 4. Anthrax X-rayed: new opportunities for biodefence.
    Stubbs MT
    Trends Pharmacol Sci; 2002 Dec; 23(12):539-41. PubMed ID: 12457764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quickening the pace of anthrax research: three advances point towards possible therapies.
    Chaudry GJ; Moayeri M; Liu S; Leppla SH
    Trends Microbiol; 2002 Feb; 10(2):58-62. PubMed ID: 11827799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiology. A binding contract for anthrax.
    Bull JJ; Parrish CR
    Science; 2002 Jul; 297(5579):201-2. PubMed ID: 12114612
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric anthrax clinical management: executive summary.
    Bradley JS; Peacock G; Krug SE; Bower WA; Cohn AC; Meaney-Delman D; Pavia AT;
    Pediatrics; 2014 May; 133(5):940-2. PubMed ID: 24777221
    [No Abstract]   [Full Text] [Related]  

  • 8. Attacking anthrax.
    Young JA; Collier JR
    Sci Am; 2002 Mar; 286(3):48-50, 54-9. PubMed ID: 11857900
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioterrorism. This time it was real: knowledge of anthrax put to the test.
    Enserink M
    Science; 2001 Oct; 294(5542):490-1. PubMed ID: 11641469
    [No Abstract]   [Full Text] [Related]  

  • 10. Solubility improvement of an anthrax toxin peptide inhibitor by rational amino acid randomization.
    Pini A; Brunetti J; Falciani C; Fabbrini M; Bracci L
    Protein Pept Lett; 2008; 15(6):562-6. PubMed ID: 18680450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A therapeutic human antibody against the domain 4 of the Bacillus anthracis protective antigen shows protective efficacy in a mouse model.
    Ahn BE; Bae HW; Lee HR; Woo SJ; Park OK; Jeon JH; Park J; Rhie GE
    Biochem Biophys Res Commun; 2019 Feb; 509(2):611-616. PubMed ID: 30606479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.
    Lim NK; Kim JH; Oh MS; Lee S; Kim SY; Kim KS; Kang HJ; Hong HJ; Inn KS
    Infect Immun; 2005 Oct; 73(10):6547-51. PubMed ID: 16177329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dominant-negative therapy for anthrax.
    Leppla SH
    Nat Med; 2001 Jun; 7(6):659-60. PubMed ID: 11385497
    [No Abstract]   [Full Text] [Related]  

  • 14. Human antibodies from immunized donors are protective against anthrax toxin in vivo.
    Wild MA; Xin H; Maruyama T; Nolan MJ; Calveley PM; Malone JD; Wallace MR; Bowdish KS
    Nat Biotechnol; 2003 Nov; 21(11):1305-6. PubMed ID: 14555959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthrax fusion protein therapy of cancer.
    Frankel AE; Powell BL; Duesbery NS; Vande Woude GF; Leppla SH
    Curr Protein Pept Sci; 2002 Aug; 3(4):399-407. PubMed ID: 12370003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of peptide-based anthrax toxin inhibitors.
    Gujraty K; Sadacharan S; Frost M; Poon V; Kane RS; Mogridge J
    Mol Pharm; 2005; 2(5):367-72. PubMed ID: 16196489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacillus anthracis and anthrax].
    Yabuuchi E
    Nihon Saikingaku Zasshi; 2003 Aug; 58(3):505-48. PubMed ID: 14524244
    [No Abstract]   [Full Text] [Related]  

  • 18. A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates from B. anthracis spore challenge.
    Mett V; Chichester JA; Stewart ML; Musiychuk K; Bi H; Reifsnyder CJ; Hull AK; Albrecht MT; Goldman S; Baillie LW; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():183-90. PubMed ID: 21270531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide inhibitors MAP the way towards fighting anthrax pathogenesis.
    DeCathelineau AM; Bokoch GM
    Biochem J; 2006 Apr; 395(1):e1-3. PubMed ID: 16541485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of phage display and polyvalency to design inhibitors of protein-protein interactions.
    Mourez M; Collier RJ
    Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.